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Abstract
The major challenge in the diagnosis of disseminated intravascular coagulation (DIC)
comes from the lack of specific biomarkers, leading to developing composite scoring sys-
tems. DIC scores are simple and rapidly applicable. However, optimal fibrin-related markers
and their cut-off values remain to be defined, requiring optimization for use. The aim of this
study is to optimize the use of DIC-related parameters through machine learning (ML)-
approach. Further, we evaluated whether this approach could provide a diagnostic value in
DIC diagnosis. For this, 46 DIC-related parameters were investigated for both clinical find-
ings and laboratory results. We retrospectively reviewed 656 DIC-suspected cases at an ini-
tial order for full DIC profile and labeled their evaluation results (Set 1; DIC, n = 228; non-
DIC, n = 428). Several ML algorithms were tested, and an artificial neural network (ANN)
model was established via independent training and testing using 32 selected parameters.
This model was externally validated from a different hospital with 217 DIC-suspected cases
(Set 2; DIC, n = 80; non-DIC, n = 137). The ANN model represented higher AUC values
than the three scoring systems in both set 1 (ANN 0.981; ISTH 0.945; JMHW 0.943; and
JAAM 0.928) and set 2 (AUC ANN 0.968; ISTH 0.946). Additionally, the relative importance
of the 32 parameters was evaluated. Most parameters had contextual importance, however,
their importance in ML-approach was different from the traditional scoring system. Our
study demonstrates that ML could optimize the use of clinical parameters with robustness
for DIC diagnosis. We believe that this approach could play a supportive role in physicians’
medical decision by integrated into electrical health record system. Further prospective vali-
dation is required to assess the clinical consequence of ML-approach and their clinical
benefit.
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Introduction
Disseminated intravascular coagulation (DIC) is a life-threatening condition which arises as a
secondary complication from a range of underlying conditions including sepsis, severe
trauma, and advanced cancer [1]. The Scientific and Standardization Committee on DIC of
the International Society on Thrombosis and Haemostasis (ISTH) define DIC as ‘an acquired
syndrome characterized by the intravascular activation of coagulation with a loss of localiza-
tion arising from different causes.’[2] Despite this definition highlighting DIC’s key features,
the major challenge in the diagnosis of disseminated intravascular coagulation (DIC) comes
from the lack of a single potent marker for DIC, leading to developing composite scoring sys-
tems, derived from underlying conditions and laboratory results [2–4].
The diagnostic criteria, widely used as a gold standard, is the ISTH criteria which consist of
platelet (PLT) count, prothrombin time (PT), fibrinogen, and fibrin-related markers (e.g. D-
dimer or fibrin degradation products; FDP) [2]. Although the ISTH criteria have been vali-
dated by various studies and the performance was shown to be satisfactory, several issues
remain [5–8]. Particularly, determination of the optimal fibrin-related markers and individual
laboratory cut-off values for moderate to strong increase have not yet been clearly defined [9–
12]. Furthermore, the ISTH criteria’s sensitivity is regarded by some to be lacking when com-
pared to other scoring systems [13]. Two other well-established scoring systems are the Japa-
nese Ministry of Health and Welfare’s criteria (JMHW criteria) and the Japanese Association
for Acute Medicine’s criteria (JAAM criteria; Table 1) [4–14]. Those criteria have respective
advantages and limitations depending on the underlying conditions, and numbers of refine-
ments have been made [10, 13, 15].
Artificial intelligence (AI)—where computers mimic human intelligence through machine
learning algorithms—has drawn media attention, and ubiquitous application of AI has grown
in momentum across various fields. Similar trials have shown up in the medical field, particu-
larly using clinical data and medical images [16–19]. Artificial neural network (ANN) resem-
bles human neuronal connections by building a multi-layered network and can be trained to
functionalize or categorize complex patterns [20, 21]. There are two remarkable characteristics
of this machine learning (ML)-approach: 1) non-linear pattern recognition and 2) improve-
ment by learning. These features are not only ideal for considering various clinical conditions,
but also for giving standardized results with wide extensibility. ANNs have demonstrated posi-
tive medical application in areas such as diagnosis of myocardial infarction, cancer, and dia-
betic retinopathy [22–24]. In this study, we demonstrated ML-approaches for DIC diagnosis
and established an optimized ANN model which integrates both the clinical findings and the
laboratory results.
Materials and methods
Patients
This study was approved by the institutional review board and the ethics committee of Yonsei
University Health System (Seoul, Korea; IRB 4-2016-0698). The current study used medical
records and participating centers have waived by completing the questionnaires. All data was
treated confidentially with anonymized numbers. Patients with full DIC profile were defined
as cases with all laboratory results including complete blood count (CBC) with differential
counts, global coagulation tests (PT, PT % activity, international normalized ratio [INR], acti-
vated partial thromboplastin time [aPTT], and thrombin time), fibrinogen, D-dimer, FDP,
and anti-thrombin III (AT III) having been ordered on the same day (this order set defined as
‘DIC profile’).
Machine learning-based diagnosis for DIC
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Eligible cases had full DIC profile orders (n = 837) between April and October 2016 at a ter-
tiary hospital (Severance Hospital, Seoul, Korea; Fig 1A). After excluding consecutive orders from
the identical patients and outpatient clinic orders, patients with initial full DIC profile after admis-
sion (n = 769) were enrolled. Cases from pediatric patients, routine orders at admission, long-
term hospitalized patients, or previous transfusion therapy were excluded (n = 113). Finally, the
development set (set 1; n = 656) remained with DIC suspected cases requiring an evaluation of
DIC. Because the cases were enrolled at initial evaluation point, no cases were previously treated
with transfusion therapy (plasma product or cryoprecipitate) or AT III. A similar approach was
used for the external validation set (set 2; n = 217) derived from data obtained from another ter-
tiary hospital (Gangnam Severance Hospital, Seoul, Korea). Demographics and clinical character-
istics of the patients are represented in Table 2. There were no cases having heparin-induced
thrombocytopenia, thrombotic microangiopathy (TMA), or antiphospholipid syndrome.
Data collection and labeling DIC status
We retrospectively followed the timeline of physicians’ diagnostic process. Therefore, the pres-
ence of clinical signs, symptoms, underlying DIC-related conditions and the full set of laboratory
results was obtained at the same day of DIC profile (Tables 2 and 3, Text A in S1 File) (9). CBC
was obtained from K2-EDTA tube using automated hematology analyzers (ADVIA 2120i; Sie-
mens Healthcare Diagnostics, IL, USA) which provide commonly reported clinical parameters
and additional research use only (RUO) parameters, such as large unstained cells (LUC; %),
delta neutrophil index (DNI), and TMA score [25–27]. Global coagulation tests and fibrin-
related markers were performed using ACL-TOP 750 analyzer (Instrumentation Laboratory,
Bedford, MA, USA), with the samples collected in 3.2% sodium citrate tubes. Noticeably, the
external validation hospital used different automated hematologic analyzers (XN-9000 and CS-
5100 system; Sysmex, Kobe, Japan) and had different DIC profile: protein C was included instead
of FDP, and RUO parameters were not provided. In this reason, four parameters were excluded
Table 1. Diagnostic scoring systems for disseminated intravascular coagulation (DIC) used in this study.
DIC criteria ISTH JMHW JAAM
Underlying condition Essential 1 p Essential
Clinical symptoms NA Bleeding: 1 p SIRS score 3: 1 p
Organ failure: 1 p
Prothrombin time (PT) Prolonged PT (sec) PT ratio PT ratio
3 <– 6: 1 p 1.25–< 1.67: 1 p  1.2: 1 p
> 6: 2 p  1.67: 2 p
Platelet count (×103/μL) 50–< 100: 1 p 80 <– 120: 1 p 80– 120 or > 30% reduction/24h: 1 p
< 50: 2 p 50 <– 80: 2 p < 80 or > 50% reduction/24h: 3 p
 50: 3 p
Fibrin-related marker FDP, D-dimer, SF FDP (μg /mL) FDP (μg /mL)
Moderate increase: 2 p 10 –< 20: 1 p 10–< 25: 1 p
Strong increase: 3 p 20 –< 40: 2 p  25: 3 p
 40: 3 p
Fibrinogen (mg/dL) < 100: 1 p 100 <– 150: 1 p NA
 100: 2 p
Score range 0–8 p 0–13 p 0–8 p
DIC diagnosis  5 p  7 p  4 p
Abbreviations: ISTH, the International Society on Thrombosis and Haemostasis; JMHW, the Japanese Ministry of Health and Welfare; JAAM, the Japanese Association
for Acute Medicine; NA, Not applicable; SF, soluble fibrin; p, point
https://doi.org/10.1371/journal.pone.0195861.t001
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Fig 1. Schematic representation of patient enrollment and development of the artificial neural network (ANN) model. (A) Full DIC profile was
defined as all laboratory results including complete blood count with differential counts, global coagulation tests (PT, PT % activity, international
normalized ratio [INR], activated partial thromboplastin time [aPTT], and thrombin time), fibrinogen, D-dimer, FDP, and anti-thrombin III. The
external validation hospital used different DIC profile: protein C was included instead of FDP, and RUO parameters were not provided. (B) ANN
model for DIC diagnosis. In the training phase, the development set (n = 656) was randomly split into training and test sets in 80:20 ratio and hyper-
parameters were determined for an optimal modeling. All layers have 32 nodes with an input-layer and two-hidden layers. The relative importance
of input features was calculated based on the ‘Connection Weight’ approach, after the ANN model was established.
https://doi.org/10.1371/journal.pone.0195861.g001
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in set 2 (Fig 2). To curate the DIC status (non-DIC: 0, DIC: 1), patient’s medical record, clinical
manifestation, and laboratory results were retrospectively reviewed by medical experts. Each
case was carefully reviewed by two experts individually and the patient’s evaluation result which
occurred within a week was assigned comprehensively depending on the laboratory data change,
clinical manifestation, clinical intervention, and final diagnosis. If a discrepancy occurred, the
case was reviewed by another third expert and labeled after a consensus was reached.
Model development
Using the collected datasets, we tested several ML algorithms including logistic regression, lin-
ear regression, ridge regression, random forest, gradient boosting machine, deep learning, and
ANN with DaVinci Labs (Solidware Inc., Seoul, Korea) which support an AI-based data analy-
sis; the performance of ANN model was the best among the seven algorithms. In the training
phase, the development set was randomly split into training and test sets in 80:20 ratio. Next,
auto-tuning for hyper-parameters (e.g. number of hidden layers, epochs) with respect to the
performance of the model on the test set was conducted. After several iterations of the auto-
tuning and training processes, an ANN model (2 hidden layers, 10 epochs) to evaluate DIC sta-
tus was established (Fig 1B). Additionally, we calculated the relative importance of the input
variables with ‘Connection Weight’ approach [28]. Briefly, the importance of variables is pro-
portional to the sum of absolute values of products between weights of connections, by which
this variable is propagated. We also conducted an external validation of the ANN model using
set 2. As set 2 was missing four variables, the ANN model was re-trained without the four vari-
ables and evaluated.
Table 2. Patient demographics and clinical characteristics.
Numbers of cases (%) Development set (set 1; n = 656) External validation set (set 2; n = 217)
DIC
(n = 228)
Non-DIC
(n = 428)
P value DIC
(n = 80)
Non-DIC
(n = 137)
P value
Age, years 60.8 ± 16.6 58.1 ± 17.5 .053 62.7 ± 15.9 64.2 ± 16.5 .228
Gender, male 119 (52.2) 225 (52.6) .992 49 (61.3) 71 (51.8) .530
Currently in ICU 155 (68.0) 171 (40.0) < .001 59 (73.8) 59 (43.1) < .001
APACHE II score ± SD  30.2 ± 10.7 24.3 ± 9.8 < .001 25.3 ± 9.7 16.2 ± 6.7 < .001
Mortality (28-days) 146 (64.0) 77 (18.0) < .001 53 (66.2) 12 (8.8) < .001
On anticoagulation therapy 2 (0.9) 32 (7.5) .001 2 (2.5) 5 (3.6) .949
Thrombosis 12 (5.3) 46 (10.7) .027 4 (5.0) 9 (6.6) .862
Bleeding 60 (26.3) 85 (19.9) .072 22 (27.5) 12 (8.8) .001
Organ failure 116 (50.9) 58 (13.6) < .001 39 (48.8) 15 (10.9) < .001
SIRS score 3 176 (77.2) 146 (34.1) < .001 66 (82.5) 53 (38.7) < .001
Associated conditions with DIC
Sepsis/Infection 161 (70.6) 140 (32.7) < .001 58 (72.5) 47 (34.3) < .001
Tissue damage 28 (12.3) 51 (11.9) .991 23 (28.7) 33 (24.1) .551
Post major surgery 34 (14.9) 133 (31.1) < .001 13 (16.2) 46 (33.6) .009
Hematologic malignancy 26 (11.4) 35 (8.2) .225 7 (8.8) 5 (3.6) .201
Solid cancer 87 (38.2) 82 (19.2) < .001 20 (25.0) 17 (12.4) .028
Hepatic failure 34 (14.9) 17 (4.0) < .001 13 (16.2) 4 (2.9) .001
Obstetric complications 4 (1.8) 21 (4.9) .073 1 (1.2) 3 (2.2) > .999
Vascular abnormalities 4 (1.8) 18 (4.2) .152 11 (13.8) 31 (22.6) .156
Immunologic insult 4 (1.8) 22 (5.1) .057 9 (11.2) 5 (3.6) .056
 The Acute Physiology and Chronic Health Evaluation (APACHE) II score was calculated only if a patient was admitted to ICU.
https://doi.org/10.1371/journal.pone.0195861.t002
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Analysis
Performance of the ANN model was compared to the three scoring systems (ISTH, JMHW,
and JAAM; Table 1). Sensitivity, specificity, positive and negative predictive value, and area
under curve (AUC) values were calculated following each criterion. D-dimer was used as the
fibrin-related marker for the ISTH criteria as both set 1 and set 2 had this parameter (cut-off
values for the moderate to the strong increase were based on 25% and 75% quartiles of all
Table 3. Laboratory results for full DIC profile parameters.
Parameters, mean (SD) Development set (set 1; n = 656) External validation set (set 2; n = 217)
DIC
(n = 228)
Non-DIC
(n = 428)
P value DIC
(n = 80)
Non-DIC
(n = 137)
P value
Global coagulation tests with DIC profile
Prothrombin time (PT; sec) 21.9 (10.3) 15.1 (6.5) < .001 20.6 (7.4) 14.6 (3.9) < .001
PT activity (%) 50.4 (18.8) 75.8 (20.9) < .001 50.4 (17.9) 77.7 (18.7) < .001
INR 1.92 (0.90) 1.32 (0.56) < .001 1.72 (0.65) 1.21 (0.34) < .001
aPTT (sec) 60.3 (36.5) 39.1 (18.8) < .001 52.2 (35.6) 31.3 (11.0) < .001
Thrombin time (sec) 21.5 (17.0) 20.0 (18.2) .297 24.9 (13.9) 19.3 (3.0) < .001
Fibrinogen (mg/dL) 304 (189) 415 (178) < .001 326 (212) 470 (202) < .001
D-dimer (μg/mL)a 8.23 (12.95) 2.10 (4.55) < .001 16.96 (18.86) 7.25 (12.16) < .001
Anti-thrombin III activity (%) 53.8 (20.0) 81.0 (24.6) < .001 50.5 (19.9) 79.8 (18.8) < .001
Fibrin degradation product (μg /mL) 59.4 (62.3) 18.0 (24.6) < .001 NAe NA NA
Protein C activity (%) NA NA NA 40.7 (19.5) 81.9 (31.4) < .001
Complete blood count and related parameters
RBC count (×106/μL) 2.97 (0.65) 3.25 (0.69) < .001 3.20 (0.89) 3.56 (0.74) .002
Hemoglobin (g/dL) 9.2 (2.0) 10.0 (2.0) < .001 9.9 (2.7) 10.9 (2.0) .003
Hematocrit (%) 27.5 (5.7) 29.8 (5.9) < .001 29.8 (8.1) 33.0 (6.4) .002
MCV (fL) 93.0 (6.8) 92.3 (5.9) .150 93.5 (6.3) 92.9 (5.7) .477
MCH (pg) 31.1 (2.3) 30.8 (2.1) .038 31.0 (2.4) 30.7 (2.4) .412
MCHC (g/dL)b 33.4 [32.4, 34.4] 33.4 [32.5, 34.2] .433 33.0 [32.1, 34.1] 33.0 [32.4, 33.6] .334
RDW (%) 16.5 (2.7) 15.4 (2.4) < .001 15.5 (2.8) 14.1 (2.0) < .001
PLT count (×103/μL) 57 (56) 168 (129) < .001 77 (78) 211 (133) < .001
PLT changes (%/24hrs)c -0.36 (0.60) -0.15 (0.33) < .001 -0.40 (0.52) -0.08 (0.32) < .001
PDW (%, fL)d 61.9 (17.2) 56.4 (10.6) < .001 13.7 (3.7) 11.5 (2.2) < .001
MPV (fL) 10.45 (1.99) 9.15 (1.49) < .001 11.36 (1.99) 10.33 (1.49) < .001
WBC count (×103/μL) 12.75 (17.60) 10.60 (9.61) .044 11.75 (17.60) 13.40 (9.61) .218
Differential count (%)
Neutrophil 77.7 (24.0) 75.5 (21.0) .226 79.9 (15.4) 78.0 (17.3) .404
Lymphocyte 13.2 (19.3) 14.4 (16.3) .423 12.5 (15.4) 13.5 (12.7) .626
Monocyte 4.8 (3.6) 5.5 (4.5) .063 6.0 (4.4) 7.0 (6.9) .250
Eosinophil 0.8 (1.5) 1.8 (3.8) < .001 1.1 (1.8) 1.3 (1.9) .566
Basophil 0.2 (0.3) 0.2 (0.2) .845 0.4 (0.7) 0.3 (0.3) .114
Large unstained cell (LUC) 3.2 (13.0) 2.2 (8.6) .277 NA NA NA
Delta neutrophil index (%) 13.5 (16.2) 5.0 (9.2) < .001 NA NA NA
Thrombotic microangiopathy score 2.7 (1.5) 2.0 (1.4) < .001 NA NA NA
a measured in data display unit (DDU; set 1) or fibrinogen-equivalent unit (FEU; set 2). See Table A in S1 File.
b Non-parametric distribution, median [25, 75 percentiles].
c The percent change in PLT count within 24 hours was calculated only if previous PLT count was available.
d The report units are different for PDW value between set 1 (%) and set 2 (fL).
e NA, not applicable
https://doi.org/10.1371/journal.pone.0195861.t003
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patients in each hospital, respectively.) [9]. JMHW and JAAM scores could not be evaluated in
set 2 as FDP was lacked in the DIC profile of set 2.
Statistics software R version 3.4.3 was used for data analysis. Datasets were visualized using
‘ComplexHeatmap’ package [29]. Performance evaluation was achieved via receiver operating
characteristic (ROC) curve analysis, and calculation of AUC using the ‘pROC’ package [30].
The cut-off value (0.501) for the ANN model was determined by the ‘OptimalCutpoints’ pack-
age using the Youden method [31]. Statistical analyses were performed by Student’s t-test for
parametric data and Mann-Whitney U test for non-parametric data. P values below 0.05 were
considered as statistically significant.
Results
Patient characteristics
We conducted a retrospective cross-sectional study of DIC-suspected patients at initial evalua-
tion with full DIC profiles. All available cases with full DIC profiles were reviewed in two
Fig 2. Heat map presentation of the datasets used in this study. The x-axis denotes individual cases and the y-axis
corresponds to the clinical variables. Each cell shows values of variables for each case. All cases are sorted horizontally
by the labeled DIC status and predicted ANN model values. Rows 2–5 (ANN model, ISTH, JMHW, and JAAM
criteria) show predictions of different DIC diagnostic classifiers based on the cut-off values (0.501 for ANN) or points
(Table 1).
https://doi.org/10.1371/journal.pone.0195861.g002
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different hospitals. After excluding cases from consecutive orders, pediatric patients, routine
orders at admission or from long-term hospitalized patients, and patients with previous trans-
fusion therapy, the development dataset was constructed from 656 patients with initial full
DIC profiles. Among the 656 patients admitted to either general ward (n = 330) or intensive
care unit (ICU; n = 326) in Set 1, 228 (34.8%) and 428 (65.2%) patients were labeled as DIC
and non-DIC status, respectively (Table 2). Univariate analysis showed no differences in age
or gender between the two groups (DIC vs. non-DIC; in the parentheses). However, the pro-
portion in ICU (68.0 vs. 40.0%, P< .001), Acute Physiology and Chronic Health Evaluation
(APACHE) II scores (30.2 vs. 24.3, P< .001) which were only calculated for ICU patients [32],
and 28-days mortalities (64.0 vs. 18.0%, P< .001) were higher in DIC group. Moreover, the
proportion of patients showing organ failure (50.9 vs. 13.6%, P< .001) and systemic inflam-
matory response syndrome (SIRS; 77.2 vs. 34.1%, P< .001) was higher in the DIC group.
Additionally, bleeding was more common in the DIC group (26.3 vs. 19.9%) although the dif-
ference was only significant at P = .072. Above clinical conditions showed similar results in Set
2.
We also investigated the DIC-related conditions, and sepsis/infection was the most com-
mon condition (70.6%) followed by solid cancer (38.2%). Sepsis/Infection (70.6 vs. 32.7%, P<
.001), solid cancer (38.2 vs. 19.2%, P< .001), and hepatic failure (14.9 vs 4.0%, P< .001) were
the underlying conditions positively correlated with the DIC group. While post major surgery
status (14.9 vs 31.1%, P< .001) tended to be more prevalent in the non-DIC group, we believe
that this was resulted by physicians’ inclination ordering DIC profile after major surgery.
Other associated conditions such as tissue damage, hematologic malignancy, obstetric compli-
cations, vascular abnormalities, and toxic or immunologic insult showed no significant result
between the two groups, although the number of such cases was relatively small.
Most laboratory results showed a difference between the DIC and non-DIC groups. Global
coagulation parameters, except thrombin time, showed different results (P< .001; Table 3).
CBC components also presented different results, except for two RBC indices and some differ-
ential counts. The relative lower levels of RBC count and hemoglobin in the DIC group may
be caused by the higher proportion of bleeding patients than the non-DIC group. We visual-
ized the two datasets with the heat map (Fig 2) which enabled us to look over the landscapes of
the data distributions. Sepsis/infection, SIRS, and ICU admission were more commonly
observed in the DIC group. PT and PLT count showed reverse predisposition, as expected.
The general patterns represented in the heat map confirmed the similar composition of the
two data sets, while vascular abnormalities were more common in the validation set due to the
vascular surgery center located at this hospital. Missing values were presented as blanks, and
seven variables contained missing values. APACHE II scores were only calculated if a patient
was admitted to ICU. PLT changes (%/24hr) were only available for patients with previous
PLT count result. WBC differential counts, PLT distribution width (PDW), Mean PLT volume
(MPV), and RUO parameters were not reported from hematologic analyzers in cases of severe
thrombocytopenia or leukopenia.
Established model and variable importance
We first tested the ANN model with 46 investigated variables and gradually excluded negligi-
ble variables. The laboratory parameters with trivial impacts on the performance were
excluded: mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC) and WBC counts. Because of the small num-
ber of the cases with trivial effects, the following clinical variables were also excluded: anticoag-
ulant use, bleeding, thrombosis, hematologic malignancy, immunologic insult, hepatic failure,
Machine learning-based diagnosis for DIC
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obstetric complication, tissue damage, and vascular abnormalities. Consequently, 32 represen-
tative variables were used in the developed ANN model including clinical signs and symptoms,
underlying conditions, and laboratory parameters.
To provide an interpretable model for each clinical variable, we calculated the relative
importance. It is noteworthy that statistical significance does not guarantee variable impor-
tance level in ANN, and vice versa. Recently, the ‘Connection Weight’ approach was reported
to be an efficient method of identifying variable importance in ANN model [33]. Fig 3 shows
the calculated importance using this approach in 32 clinical variables. Most parameters such as
PLT count (8.74%), PLT changes (4.86%), D-dimer (4.13%), and FDP (3.96%) had contextual
importance in accordance with DIC features, whereas fibrinogen level (2.43%) showed rela-
tively low importance. PLT count and PLT changes ranked as the first and third important var-
iable and these results were expectable owing to the evident statistical differences between the
DIC and non-DIC groups (57 vs. 168 ×103/μL, P< .001; -0.36 vs. -0.15, P< .001). To mini-
mize inter-laboratory variations, three PT parameters (sec, INR, percent activity) were sepa-
rately used in the model, because INR and PT % activity is a standardized value using normal
pooled plasma. Although separately evaluated, PT parameters occupied a total of 8.94% of the
entire importance level and also played a significant role. Interestingly, the importance of pre-
viously overlooked parameters was not negligible in the ANN model including PDW (varia-
tions in PLT size and shape), red cell distribution width (RDW; variations in RBC size and
shape), and RUO parameters. Most parameters presented a contextual importance, however,
their importance in the ML-approach was different from the traditional approach.
Performance
The performance of four methods was compared in terms of AUC values, sensitivity, specific-
ity, and predictive values (Table 4). Among the four methods, the ANN model showed the best
AUC value with P< .001 while the three DIC criteria presented no differences (Fig 4A). The
AUC (95% confidence interval; CI) of the ANN model was 0.981 (0.973–0.989) and the three
DIC criteria had AUC of 0.945 (0.929–0.962) for the ISTH, 0.943 (0.927–0.959) for the
JMHW, and 0.928 (0.909–0.946) for the JAAM, respectively. The optimal cut-off value by You-
den index for the ANN model was 0.501 with 89.9% (85.2–93.5) and 96.0% (93.7–97.7) of the
sensitivity and specificity (95% CI), respectively. Additionally, the sensitivity and specificity of
the three DIC criteria were 82.0% (76.4–86.8), 93.7% (91.0–95.8) for the ISTH, 91.2% (86.8–
94.6), 84.3% (80.6–87.7) for the JMHW, and 94.7% (91.0–97.3), 79.0% (74.8–82.7) for the
JAAM, respectively. All methods showed relatively lower performance than the previous pro-
spective study in the ICU setting using the ISTH criteria (sensitivity 91%, specificity 97%) [5].
The difference may be attributed to the study design, the patient composition and ward setting,
the hematologic analyzer, and/or variance in the expert opinion. Nevertheless, the ISTH crite-
ria showed relatively low sensitivity and high specificity, while the JMHW showed relatively
high sensitivity and low specificity, as reported [9]. Furthermore, we reviewed the performance
in the external validation set (n = 217). The ANN model was re-trained without the four vari-
ables (FDP and RUO parameters) which were included in set 1, and the AUC value of this
model without the four variables was 0.975 (0.966–0.984). Using this model, we tested set 2,
and the AUCs were 0.968 (0.945–0.986) for the ANN model and 0.946 (0.916–0.976) for the
ISTH (Fig 4B, Table 4). Both models showed slightly compromised results, while the ISTH
remained with constant AUC with slightly skewed performance–low sensitivity and high spec-
ificity. The compromised AUC portion in the ANN model may primarily come from the dif-
ferent hospital setting, the different reference intervals, and/or the unstandardized measured
values from analyzers. Nevertheless, the ANN model showed overall higher performance than
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the ISTH criteria. Because of the small numbers of cases in set 2, it was inevitable that the 95%
CI overlapped with the performance of ISTH criteria.
Discussion
This study demonstrated ML-approach for DIC diagnosis to optimally integrate the DIC-
related parameters. The established model enrolled 32 clinical parameters and the study shed
light on the buried roles of overlooked clinical parameters in the scoring systems. However,
the clinical implication of the enrolled variables remained uncertain to further investigation.
We suggest that a number of additional cases with excluded variables should be obtained to
precisely evaluate the role of anticoagulant use, bleeding, thrombosis, hematologic malignancy,
immunologic insult, hepatic failure, obstetric complication, tissue damage, and vascular
abnormalities in ML-approach. Therefore, the current ANN model may need to be further
updated and validated with bigger data sets. Nevertheless, we believe that this approach may
facilitate the diagnosis of DIC and the performance can be further improved by adding diverse
training data and applying more advanced algorithms and parameters.
The major limitation of this study is DIC labeling procedure. Labeled results could be
biased by the medical experts and by the limitation of retrospective approach. We employed
supervised learning method which is generally used for classification and risk prediction in
medicine [17]. In this approach, supervised labels determine the developed model. Although
we labeled DIC status after expert agreements with careful medical record reviews, the labeled
Fig 3. Relative importance of clinical and laboratory variables in the ANN model. In the developed ANN model, 32 variables are used and their
relative importance is calculated based on the weight value, reflecting connectivity of neurons, using ‘Connection Weight’ approach to provide
explanatory insights for each variable. (Total sum: 100%, average importance: 3.13%).
https://doi.org/10.1371/journal.pone.0195861.g003
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results can be incorrect or uncertain [34]. Moreover, we only enrolled the cases at the initial
orders with varying elapsed time to diagnose, therefore consecutive monitoring of DIC profile
was not possible except PLT changes. Because DIC is a rapid and dynamic change in blood
vessels, an ML model reflecting consecutive changes of variable laboratory parameters would
be developed in the future. These reasons may potentially play as limitations and could have
affected the current model. Recently, several advancements in ML algorithms have been
reported to overcome variations in human expert opinion. We expect that rapid advancement
in ML algorithms may cover such issues in the future. ML cannot go beyond what’s contained
in data. Meaning that more powerful and specific tests are still required for DIC diagnosis.
Some studies have shown the usefulness of several methods in diagnosing DIC such as throm-
boelastography, clot waveform analysis, damage-associated molecular patterns, histone-DNA
complexes, and circulating histones [13]. Additional data from such potential assays may also
improve the performance.
Developing an AI system that gives contextual rationale is another important issue in the
medical application. ANN is occasionally described as a ‘black box’ as it provides little explana-
tory insight into the variables [28]. However, recent studies illuminated substantial part of this
‘black box’ with a range of approaches. In order to provide intuitive information on clinical
parameters, we calculated the relative importance and the values were mostly circumstantial to
DIC features; absolute PLT count and changes, fibrin-related markers, PT prolongation were
also important features in the ANN model, whereas fibrinogen level had relatively low impor-
tance. Additionally, some overlooked laboratory parameters such as PDW, RDW, and RUO
parameters operated considerably in the ANN machinery. As a result of DIC progression,
Table 4. Diagnostic performance of disseminated intravascular coagulation (DIC) diagnostic classifiers in this study.
Dataset DIC criteria DIC Non-DIC AUC
(95% CI)
Diagnostic performance (95% CI)
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Positive
LR
Negative
LR
Set 1
(n = 656)
ANN 0.981
(0.973–0.989)
89.9
(85.3–93.5)
96.0
(93.7–97.7)
92.3
(88.3–95.1)
94.7
(92.4–96.3)
22.64
(14.18–36.14)
0.11
(0.07–0.15)Positive 205 17
Negative 23 411
ISTH 0.945
(0.929–0.962)
82.0
(76.4–86.8)
93.7
(91.0–95.8)
87.4
(82.7–90.9)
90.7
(88.1–92.8)
13.00
(8.98–18.82)
0.19
(0.15–0.25)Score 5 187 27
Score < 5 41 401
JMHW 0.943
(0.927–0.959)
91.2
(86.8–94.6)
84.4
(80.6–87.7)
75.6
(71.3–79.5)
94.8
(92.2–96.5)
5.83
(4.66–7.29)
0.10
(0.07–0.16)Score 7 208 67
Score < 7 20 361
JAAM 0.928
(0.909–0.946)
94.7
(91.0–97.3)
79.0
(74.8–82.7)
70.6
(66.6–74.3)
96.6
(94.2–98.0)
4.51
(3.74–5.43)
0.07
(0.04–0.12)Score 4 216 90
Score < 4 12 338
Set 2
(n = 217)
ANN 0.968
(0.945–0.986)
90.0
(81.2–95.6)
93.4
(87.9–97.0)
88.9
(80.9–93.8)
94.1
(89.2–96.9)
13.7
(7.25–25.87)
0.11
(0.06–0.22)Positive 72 9
Negative 8 128
ISTH 0.946
(0.916–0.976)
82.5
(72.4–90.1)
95.6
(90.7–98.4)
91.7
(83.3–96.0)
90.3
(85.3–93.8)
18.84
(8.56–41.46)
0.18
(0.11–0.29)Score 5 66 6
Score < 5 14 131
ANN, artificial neural network; ISTH, the International Society on Thrombosis and Haemostasis; JMHW, the Japanese Ministry of Health and Welfare; JAAM, the
Japanese Association for Acute Medicine; CI, Confidence Interval; AUC, area under curve; PPV, positive predictive value; NPV, negative predictive value; LR, likelihood
ratio.
 Cut-off values for ANN model was determined at 0.501.
https://doi.org/10.1371/journal.pone.0195861.t004
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increases in PDW and MPV may be caused by a morphological transformation of PLT activa-
tion and young PLT production by megakaryopoiesis [35] that may explain the supportive
role of PDW (3.28%) and MPV (1.48%). Additionally, mechanical damage to RBC during DIC
progression such as schistocyte production may explain the importance of RDW (3.03%) [36].
Furthermore, TMA score (4.43%), an RUO parameter originally developed for the detection of
TMA and reported to be linked to thrombocytopenia associated multiple organ failure, was
revealed to be a supportive classifier for DIC [26]. DNI is another RUO parameter reflecting
immature granulocyte percentages in circulating blood and has been reported to be a useful
marker for sepsis. Because DIC commonly associated with sepsis, DNI (2.49%) may relate to
this proportion in the ANN model [27]. Although most of the ranks of variable importance
were understandable, it was difficult to interpret the relationships of some variables such as
eosinophil (3.82%), lymphocyte (3.81%), and monocyte (3.31%) percentages. Those CBC
Fig 4. Diagnostic performance of ANN model and scoring systems with receiver operating characteristic curve analysis and density plot. (A)
Training (Set 1): ANN model shows the best performance among the four diagnostic classifiers. The area under curve (AUC) values: ANN (0.981),
ISTH (0.945), JMHW (0.943), and JAAM (0.928). (B) External validation (Set 2): four variables were unavailable owing to the different hematologic
analyzers, therefore the AUC value was compromised compared to the development set in the ANN model; ANN (0.968), ISTH (0.946). (C, D)
Density plots of two represented diagnostic classifiers (ANN model, ISTH criteria) shows that the ANN model far obviously differentiates two groups
(DIC and non-DIC). The cut-off value for the ANN model is determined at 0.501.
https://doi.org/10.1371/journal.pone.0195861.g004
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differential count parameters may be negatively related to neutrophilia which is primarily
induced by infection or malignancy and frequently accompanied with DIC.
Laboratory results vary among institutions even when the sample is identical. Because
many laboratory parameters are required in this tool, standardization of their parameters
remains problematic and must be addressed to reduce variation between institutions. Particu-
larly, D-dimer assays, the salient variable in DIC evaluation, exploited various measuring prin-
ciples with a lack of standardized calibrators and reporting units which lead to wide inter-
laboratory and inter-method variability (Table A in S1 File) [37]. We believe that the best way
is to use a normalized value such as scaled values or z-score, however, it is not practically possi-
ble for all laboratory parameters and is remained to be solved. This standardization issue
should be always considered in the ML approach using laboratory parameters.
In conclusion, our study demonstrates a novel strategy to optimize the DIC diagnostic pro-
cess with DIC-related parameters using ML-approach. The results showed some improvement
of the diagnostic power in the retrospective design and provided additional insights into the
importance of the DIC-related parameters. We believe this approach could be implemented in
electrical health record system as a clinical decision support system in the near future. How-
ever, further prospective validation is required to assess the relationship between the ML-
approach and their clinical benefit.
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